Holen Sie sich die Stockscreener-App
16.78
2.01%
0.33
Handel nachbörslich:
16.86
0.08
+0.48%
Schlusskurs vom Vortag:
$16.45
Offen:
$16.51
24-Stunden-Volumen:
14.61M
Relative Volume:
1.77
Marktkapitalisierung:
$11.66B
Einnahmen:
$2.80B
Nettoeinkommen (Verlust:
$-10.95M
KGV:
-297.52
EPS:
-0.0564
Netto-Cashflow:
$1.15B
1W Leistung:
-2.16%
1M Leistung:
+3.58%
6M Leistung:
-0.71%
1J Leistung:
-16.35%
1-Tages-Spanne:
$16.22
$16.81
1-Wochen-Bereich:
$16.22
$17.38
52-Wochen-Spanne:
$15.71
$21.28
Healthpeak Properties Inc Stock (DOC) Company Profile
Firmenname
Healthpeak Properties Inc
Sektor
Telefon
949-407-0700
Adresse
4600 SOUTH SYRACUSE STREET, DENVER, WI
Vergleichen Sie DOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOC
Healthpeak Properties Inc
|
16.78 | 11.43B | 2.80B | -10.95M | 1.15B | -0.0564 |
|
WELL
Welltower Inc
|
185.48 | 128.69B | 9.90B | 967.82M | 1.88B | 1.3269 |
|
VTR
Ventas Inc
|
77.73 | 36.49B | 5.56B | 247.25M | 1.24B | 0.5291 |
|
OHI
Omega Healthcare Investors Inc
|
42.96 | 12.69B | 1.08B | 448.00M | 779.91M | 1.61 |
|
AHR
American Healthcare Reit Inc
|
46.82 | 8.58B | 2.07B | -37.81M | 84.15M | -0.27 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Neutral |
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-09-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-08-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-07-29 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-01-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-10-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-04-26 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-04-22 | Fortgesetzt | Mizuho | Buy |
| 2024-04-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-03-25 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-03-08 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2024-01-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-05 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-19 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-04-26 | Eingeleitet | Barclays | Overweight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-07 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2021-09-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-20 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2020-12-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-30 | Fortgesetzt | Robert W. Baird | Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Buy |
| 2020-04-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-01 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-03-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-02-27 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2019-12-20 | Eingeleitet | Mizuho | Buy |
| 2019-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-26 | Hochstufung | Stifel | Hold → Buy |
| 2019-10-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-06-20 | Eingeleitet | Citigroup | Neutral |
| 2019-05-02 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2018-08-03 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2018-04-25 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-01-05 | Bestätigt | Robert W. Baird | Outperform |
| 2017-11-06 | Hochstufung | Hilliard Lyons | Long-term Buy → Buy |
Alle ansehen
Healthpeak Properties Inc Aktie (DOC) Neueste Nachrichten
Execution Risks Cloud Healthpeak’s Janus Living Offering Amid Market and Regulatory Uncertainty - TipRanks
2 REITs That Look Attractive in a Stable Rate Environment - Investing.com
2 REITs That Look Attractive in a Stable Rate Environment - MarketBeat
Evercore ISI Group Lowers Price Target for Healthpeak Properties (DOC) | DOC Stock News - GuruFocus
Healthpeak Properties (NYSE:DOC) Given New $19.00 Price Target at Evercore ISI - MarketBeat
Healthpeak Properties (DOC) Is Down 7.1% After Earnings Beat And Janus Living IPO Plan AnnouncementHas The Bull Case Changed? - Yahoo Finance
Healthpeak Properties, Inc. (NYSE:DOC) Q4 2025 Earnings Call Transcript - Insider Monkey
Equity Investment Corp Has $102.09 Million Stock Position in Healthpeak Properties, Inc. $DOC - MarketBeat
Healthpeak Properties awaits Janus Living IPO with $360 million pipeline - McKnight's Senior Living
Healthpeak Properties Q4 Earnings Call Highlights - MarketBeat
Healthpeak Properties shares fall after Q4 FFO beats but outlook weakens - AlphaStreet
Healthpeak Properties Navigates Lab Slump With Defensive Growth - TipRanks
Research Alert: CFRA Maintains Hold Opinion On Healthpeak Properties Inc. - 富途牛牛
Healthpeak's Life Science and Medical Office Portfolios Should Produce Solid Growth Over Long Term - Morningstar
HEALTHPEAK PROPERTIES, INC. SEC 10-K Report - TradingView
Goldman Sachs Highlights Improving Occupancy and Cash Flow Visibility at Healthpeak Properties Inc. (DOC) - Insider Monkey
Healthpeak Properties Inc (DOC) Q4 2025 Earnings Call Highlights: Strategic Moves and Challenges in Focus - GuruFocus
Earnings Call Summary | Healthpeak Properties(DOC.US) Q4 2025 Earnings Conference - 富途牛牛
Healthpeak Q4 FFO Beats Estimates, Same-Store NOI Rises Y/Y - The Globe and Mail
Earnings call transcript: Healthpeak Properties Q4 2025 beats forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Healthpeak Properties Q4 2025 beats forecasts - Investing.com
Healthpeak's Pivot: A Masterclass In Value Destruction (Rating Downgrade) (NYSE:DOC) - Seeking Alpha
Healthpeak Properties (DOC) Declares Monthly Dividend and Beats Q4 Expectations - GuruFocus
Healthpeak Properties stock outlook falls short as Baird maintains rating By Investing.com - Investing.com India
Healthpeak Properties stock outlook falls short as Baird maintains rating - Investing.com
Evercore ISI Adjusts Healthpeak Properties Price Target to $22 From $21 - marketscreener.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What Are Wall Street Analysts' Target Price for Healthpeak Properties Stock? - Barchart.com
Healthpeak Properties Q4 2025 Earnings & Revenue Top Estimates | DOCNews and Statistics - IndexBox
Healthpeak Properties earnings beat by $0.09, revenue topped estimates - Investing.com Canada
Healthpeak Properties Inc (NYSE:DOC) Reports Strong Q4 2025 Earnings Beat and Unveils Major Portfolio Reshaping Strategy - Chartmill
Healthpeak Properties (DOC) Q4 Earnings Beat Estimates, Guidance Falls Short - GuruFocus
Healthpeak Properties (NYSE:DOC) Releases FY 2026 Earnings Guidance - MarketBeat
HEALTHPEAK PROPERTIES ($DOC) Releases Q4 2025 Earnings - Quiver Quantitative
Healthpeak (DOC) Beats Q4 FFO and Revenue Estimates - Yahoo Finance
Healthpeak Properties (DOC) Projects Lower FY26 FFO - GuruFocus
DOC Ventures Into Strategic Growth and Innovation - GuruFocus
Healthpeak Unveils Janus Living IPO and Portfolio Strategy - TipRanks
Healthpeak: Fourth Quarter Earnings Overview - Bitget
Healthpeak Properties (NYSE:DOC) Issues Quarterly Earnings Results - MarketBeat
Healthpeak Properties narrowly tops Q4 FFO consensus, posts soft guidance (DOC:NYSE) - Seeking Alpha
Healthpeak Properties Q4 Earnings Report: What Investors Need to Know - Benzinga
Healthpeak: Q4 Earnings Snapshot - marketscreener.com
Healthpeak Properties Inc outlook 2026 diluted earnings per common share from $0.34$0.38 - marketscreener.com
Healthpeak Properties Q4 FFO as Adjusted, Revenue Rise; 2026 Guidance Set - marketscreener.com
Healthpeak to launch senior housing REIT amid $1 billion asset recycling - Investing.com
Healthpeak Properties beats Q4 estimates, plans senior housing REIT IPO By Investing.com - Investing.com Australia
Healthpeak Properties provides strategic initiatives update and reports fourth quarter 2025 results - marketscreener.com
(DOC) Healthpeak Properties Expects 2026 FFO as Adjusted Per Share of $1.70-$1.74 - marketscreener.com
Healthpeak Properties' Q4 net income beats estimates - TradingView
Earnings Summary: Healthpeak Properties Q4 - Benzinga
Finanzdaten der Healthpeak Properties Inc-Aktie (DOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
2.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):